Tumor Uptake of 64Cu-DOTA-Trastuzumab in Patients with Metastatic Breast Cancer

The goal of this study was to characterize the relationship between tumor uptake of 64Cu-DOTA-trastuzumab as measured by PET/CT and standard, immunohistochemistry (IHC)-based, histopathologic classification of human epidermal growth factor receptor 2 (HER2) status in women with metastatic breast can...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of nuclear medicine (1978) 2018-01, Vol.59 (1), p.38-43
Hauptverfasser: Mortimer, Joanne E, Bading, James R, Park, Jinha M, Frankel, Paul H, Carroll, Mary I, Tran, Tri T, Poku, Erasmus K, Rockne, Russell C, Raubitschek, Andrew A, Shively, John E, Colcher, David M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!